bpc 157 safety toxicity Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of and Related Therapeutics Regeneration or Risk? A Narrative
Description
Uses Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, safe in inflammatory bowel disease clinical trials (GEPPPGKPADDAGLV, M.W
However, by three weeks of cuprizone consumption, dying oligodendrocytes condense, but are unfragmented, and no longer co-label with CC-3 [278]
This format is ideal for dose-response studies and extended experimental protocols
Most patients stay on a combined protocol for at least three to six months to experience optimal results
